Concepedia

Author

Frank Sirotnak

Memorial Sloan Kettering Cancer Center

Also Known As

Frank M. Sirotnak, Frank Sirotnak

7

Publications

559

Citations

6

H-Index

14

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center
FS

About

Frank Sirotnak is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacology, radiation oncology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

164

2

Medicine

2

2

164

3

Immunology

2

2

164

4

Biochemistry

1

1

11

5

Pathology

1

1

86

Frank Sirotnak

×

6

Publications

559

Citations

6

H-Index

YearCitations

Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked Activity in T-Cell Malignancies

Owen A. O’Connor, Steven M. Horwitz, Paul A. Hamlin,

Journal of Clinical Oncology

2009

181

Pulsatile Administration of the Epidermal Growth Factor Receptor Inhibitor Gefitinib Is Significantly More Effective than Continuous Dosing for Sensitizing Tumors to Paclitaxel

David B. Solit, Yuhong She, Jose Lobo,

Clinical Cancer Research

2005

134

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier‐type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T‐cell lymphoma

Owen A. O’Connor, Paul A. Hamlin, Carol S. Portlock,

British Journal of Haematology

2007

86

Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro

Hong Lin, Yuhong She, Barrie R. Cassileth,

International Immunopharmacology

2003

78

The Schedule-Dependent Effects of the Novel Antifolate Pralatrexate and Gemcitabine Are Superior to Methotrexate and Cytarabine in Models of Human Non-Hodgkin's Lymphoma

Lorraine E. Toner, Radovan Vrḫovac, Emily A. Smith,

Clinical Cancer Research

2006

69

Synthesis of the 7-Hydroxy Metabolites of Methotrexate and 10-Ethyl-10-Deazaaminopterin

Marcia I. Dawson, David Okrongly, Peter D. Hobbs,

Journal of Pharmaceutical Sciences

1987

11

Page 1